Enhanced quality of hESC‐derived melanocytes through modified concentration of endothelin‐1

Author:

Zeng Xuanhao1ORCID,Lv Haozhen2,Jin Yiting3,Liu Yating1,Wang Jinqi1,Lian Weiling1,Huang Shiyi1,Shen Jiayi1,Wu Fuyue4,Zhang Qi15,Xu Jinhua15ORCID

Affiliation:

1. Department of Dermatology, Huashan Hospital Fudan University Shanghai China

2. Department of Dermatology, Beijing Hospital, National Center of Gerontology Institute of Geriatric Medicine, Chinese Academy of Medical Sciences Beijing China

3. Department of Thyroid and Breast Surgery, General Surgery Huashan Hospital, Fudan University Shanghai China

4. ReMed Regenerative Medicine Clinical Application Institute Shanghai China

5. The Shanghai Institute of Dermatology Shanghai China

Abstract

AbstractThe study investigated the effectiveness of EDN1 and EDN3 cytokines in the differentiation of melanocytes from hESCs. The findings showed that 100 nM EDN1 was more effective in promoting hESC to CD117+/TYR+ melanoblasts compared to 100 nM EDN3. Additionally, maintaining melanoblasts is beneficial for preserving the ability to proliferate. The study found that 10 nM EDN1 helped maintain the proliferation of melanoblasts without over maturing them into melanocytes in the late stage of differentiation. Thus, using 100 nM EDN1 in the initial stage and 10 nM EDN1 in the late stage proved to be an efficient and cost‐effective method for obtaining hESC‐derived melanocytes. The preliminary results suggest that EDN1 promotes melanoblast formation during the initial differentiation stage through its binding to both the EDNRB receptor and EDNRA receptor. This study provides a valuable tool for studying the development of human melanocytes and modelling the biology of disease.

Funder

National Natural Science Foundation of China

Science and Technology Commission of Shanghai Municipality

Shanghai Municipal Health and Family Planning Commission

Publisher

Wiley

Subject

Dermatology,Molecular Biology,Biochemistry

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3